Nature Communications (Nov 2023)
How carvedilol does not activate β2-adrenoceptors
- Robert J. Lefkowitz,
- Howard A. Rockman,
- Paul J. Shim,
- Samuel Liu,
- Seungkirl Ahn,
- Biswaranjan Pani,
- Sudarshan Rajagopal,
- Sudha K. Shenoy,
- Michel Bouvier,
- Jeffrey L. Benovic,
- Stephen B. Liggett,
- Robert R. Ruffolo,
- Michael R. Bristow,
- Milton Packer
Affiliations
- Robert J. Lefkowitz
- Department of Medicine, Duke University
- Howard A. Rockman
- Department of Medicine, Duke University
- Paul J. Shim
- Department of Medicine, Duke University
- Samuel Liu
- Department of Medicine, Duke University
- Seungkirl Ahn
- Department of Medicine, Duke University
- Biswaranjan Pani
- Department of Medicine, Duke University
- Sudarshan Rajagopal
- Department of Medicine, Duke University
- Sudha K. Shenoy
- Department of Medicine, Duke University
- Michel Bouvier
- Department of Biochemistry and Molecular Medicine, Université de Montréal
- Jeffrey L. Benovic
- Department of Biochemistry and Molecular Biology, Thomas Jefferson University
- Stephen B. Liggett
- Departments of Molecular Pharmacology and Medicine, University of South Florida College of Medicine
- Robert R. Ruffolo
- Research & Development, Wyeth Pharmaceuticals
- Michael R. Bristow
- Department of Medicine, Division of Cardiology, University of Colorado - Anschutz Medical Campus
- Milton Packer
- Baylor University Medical Center
- DOI
- https://doi.org/10.1038/s41467-023-42848-5
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 3
Abstract
No abstracts available.
